SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 9th, 2016 • Vascular Biogenics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJune 9th, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 7, 2016, between Vascular Biogenics Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).